• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEVICOR MEDICAL PRODUCTS INC. MAMMOMARK; BIOPSY SITE IDENTIFIER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEVICOR MEDICAL PRODUCTS INC. MAMMOMARK; BIOPSY SITE IDENTIFIER Back to Search Results
Model Number MAM3008
Device Problem Device Damaged by Another Device (2915)
Patient Problem Foreign Body In Patient (2687)
Event Date 03/18/2019
Event Type  Injury  
Manufacturer Narrative
The mammomark biopsy site identifier is intended for use after an open surgical or percutaneous breast biopsy procedure to mark the biopsy site.The device is not available for analysis, which precludes a full investigation and analysis of the root cause.Our mammotome vacuum assisted biopsy probes contain extremely sharp edges along the aperture opening to effectively excise tissue.Removing the marker delivery system separately from the probe aperture once the spring is exposed creates the possibility of it catching on one of these edges.As a mitigation step to address this risk, we provide instructions within the instructions for use: directions: remove the delivery system and mammotome probe together as a single unit from the site, properly dispose and obtain images to confirm marker placement.Based on the patient consequence of an unintended piece of the device in the biopsy site, and the additional surgical procedure to remove, and pursuant to 21 cfr 803, we are submitting this medwatch report.
 
Event Description
Devicor medical products, inc.Received a report from our affiliate, (b)(4), stating, during the procedure the drop button was hard to use and defective so the tip of the marker applicator has been stuck in the aperture of the probe and cut during pulling back to remove from the probe.The tip of the marker applicator is inside the patient's breast.The patient is scheduled to have surgery to remove the cancerous lesion revealed by the vacuum assisted biopsy procedure; the applicator tip will be removed at that time.The patient has not complained of any secondary effects.This has been documented in our system as record # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAMMOMARK
Type of Device
BIOPSY SITE IDENTIFIER
Manufacturer (Section D)
DEVICOR MEDICAL PRODUCTS INC.
300 e. business way
fifth floor
cincinnati OH 45241
Manufacturer (Section G)
DEVICOR MEDICAL PRODUCTS DE MEXICO
sor juana ines de la cruz
#20152 4-b, parque industrial
tijuana, baja california
Manufacturer Contact
jill burnett
300 e. business way
fifth floor
cincinnati, OH 45241
MDR Report Key8504925
MDR Text Key141629317
Report Number3008492462-2019-00016
Device Sequence Number1
Product Code NEU
UDI-Device Identifier00841911100447
UDI-Public(01)00841911100447(17)200303(10)F11835480D
Combination Product (y/n)N
PMA/PMN Number
K082278
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/03/2020
Device Model NumberMAM3008
Device Catalogue NumberMAM3008
Device Lot NumberF11835480D
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/19/2019
Initial Date FDA Received04/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/30/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-